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Abstract
Background: Rett syndrome (RTT) is a severe neurodevelopmental disorder characterized by regression of language
and motor skills, cognitive impairment, and frequent seizures. Although the diagnostic criteria focus on communication,
motor impairments, and hand stereotypies, behavioral abnormalities are a prevalent and disabling component of the
RTT phenotype. Among these problematic behaviors, anxiety is a prominent symptom. While the introduction of the
Rett Syndrome Behavioral Questionnaire (RSBQ) represented a major advancement in the field, no systematic
characterization of anxious behavior using the RSBQ or other standardized measures has been reported.
Methods: This study examined the profiles of anxious behavior in a sample of 74 girls with RTT, with a focus on
identifying the instrument with the best psychometric properties in this population. The parent-rated RSBQ, Anxiety,
Depression, and Mood Scale (ADAMS), and Aberrant Behavior Checklist-Community (ABC-C), two instruments previously
employed in children with neurodevelopmental disorders, were analyzed in terms of score profiles, relationship with age
and clinical severity, reliability, concurrent validity, and functional implications. The latter were determined by regression
analyses with the Vineland Adaptive Behavior Scales-Second Edition (Vineland-II) and the Child Health Questionnaire
(CHQ), a quality of life measure validated in RTT.
Results: We found that scores on anxiety subscales were intermediate in range with respect to other behavioral
constructs measured by the RSBQ, ADAMS, and ABC-C. Age did not affect scores, and severity of general anxiety was
inversely correlated with clinical severity. We demonstrated that the internal consistency of the anxiety-related subscales
were among the highest. Test-retest and intra-rater reliability was superior for the ADAMS subscales. Convergent and
discriminant validity were measured by inter-scale correlations, which showed the best profile for the social anxiety
subscales. Of these, only the ADAMS Social Avoidance showed correlation with quality of life.
Conclusions: We conclude that anxiety-like behavior is a prominent component of RTT’s behavioral phenotype, which
affects predominantly children with less severe neurologic impairment and has functional consequences. Based on
available data on standardized instruments, the ADAMS and in particular its Social Avoidance subscale has the best
psychometric properties and functional correlates that make it suitable for clinical and research applications.
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Background
Rett syndrome (RTT; OMIM 312750), the second most
common cause of severe intellectual disability (ID) in fe-
males, is a neurodevelopmental disorder that affects 1
per 10,000 females by the age of 12 [1]. Over 95 % of indi-
viduals with RTT have mutations in methyl-CpG-binding
protein (MECP2), a gene on Xq28, which encodes a tran-
scriptional regulator [2–4]. MeCP2 is a protein involved
in synaptic development and maintenance [5, 6]. The
diagnosis of RTT is clinical; approximately 98 % individ-
uals who meet diagnostic criteria for typical RTT have a
MECP2 mutation, while about 80 % of those meeting cri-
teria for atypical RTT carry a MECP2 mutation [4, 7].
However, 3–5 % of individuals meeting diagnostic criteria
for RTT do not have a MECP2 mutation [4]. While the
overall clinical presentation varies across individuals,
some mutations have been associated with a more se-
vere phenotype, including p.Arg106Trp, p.Thr158Met,
p.Arg168X, p.Arg255X, p.Arg270X, and large deletions.
However, other mutations have a relatively milder pheno-
type, such as p.Arg133Cys, p.Arg294X, p.Arg306Cys, and
3′ truncations [3, 8, 9]. Although RTT is not considered a
progressive disorder, the clinical severity of most muta-
tions increases with age [3].
The diagnosis of RTT is based on the gradual or sud-
den loss of previously acquired fine motor and expres-
sive language skills, as well as the appearance of hand
stereotypies and gait abnormalities [7]. The regression
period can occur as early as 6 months or as late as
5 years but typically begins around 12 to 18 months of
age [7, 10, 11]. Other common features of the disorder,
which are considered supportive diagnostic criteria, in-
clude growth retardation, breathing disturbances when
awake, scoliosis/kyphosis, and decreased response to
pain [7]. Although only inappropriate laughing/scream-
ing spells are considered a diagnostically supportive
manifestation [7], behavioral abnormalities are prevalent
and impairing in RTT [12–16]. Underscoring the close
link between MeCP2 deficits and abnormal behavior,
mouse models of Mecp2 deficiency recapitulate many of
the features of the RTT phenotype including anxiety-like
behaviors [17], impaired social behaviors [18], and
stereotypic limb motions [19].
Earlier reports of abnormal behavior in humans with
RTT focused on autistic features, which typically mani-
fest during regression. In 1983, Hagberg and colleagues
first described the disorder in the English literature as a
‘progressive syndrome of autism, dementia, ataxia, and
loss of purposeful hand use in girls’ [20]. Since then, nu-
merous studies have further evaluated the presence of
autistic features in RTT and found that, along with the
loss of expressive language and the emergence of repeti-
tive hand movements, social withdrawal behaviors also
contributed to the large proportion of individuals meeting
Diagnostic and Statistical Manual of Mental Disorders
(DSM)-IV criteria for pervasive developmental disorder
not otherwise specified (PDD-NOS) [21–23]. Unlike these
relatively well-described autistic features, significantly less
is known about anxiety-like behaviors in RTT [13, 16].
Several studies report a high prevalence of anxiety and
mood disturbances in RTT, such as self-abuse, scream-
ing episodes, abrupt mood changes, and inconsolable
crying [15, 16, 24–29]. Mount and colleagues made a
major contribution to our understanding of aberrant be-
havior in RTT by developing the Rett Syndrome Behav-
iour Questionnaire (RSBQ), a rating scale specific to
RTT that covers a wide range of problem behaviors [21].
Although the RSBQ has been validated against samples
of females with intellectual disability of unknown cause,
total scale scores are difficult to interpret since they are
influenced by multiple items that are considered more
neurologic than behavioral in nature, such as breathing
abnormalities, gross motor function, and repetitive hand
movements (e.g., Breathing Problems contribute 7.3 %
variance vs. Fear/Anxiety 5.2 %) [21]. Furthermore,
RSBQ subscale scores are not independent factors since
they are highly correlated [16]. One of the first applica-
tions of the RSBQ to the characterization of anxiety and
mood disturbances was the report in 2006 by Robertson
et al. who examined genotype-behavioral phenotype cor-
relations in a large cohort of RTT females (n = 135).
Using the RSBQ’s General Mood and Fear/Anxiety sub-
scales, the study reported that individuals with milder
mutations (p.Arg133Cys, p.Arg306Cys, p.Arg294X) were
more likely to report mood difficulties and/or signs of
fear/anxiety. The association was inverse in those with
more severe mutations, who were less likely to report
mood disturbances (p.Thr158Met) or fear/anxiety
(p.Arg168X) [25]. A recent update to these data reports
that individuals with p.Arg133Cys, p.Arg294X, and large
deletions are more likely to experience mood problems
and that those with p.Thr158Met and p.Arg168X muta-
tions had reduced likelihood of anxiety [12].
Although literature on the subject is lacking, clinical
experience in RTT demonstrates that anxiety symptoms
may be severe enough to require treatment with psycho-
active medications, such as, the selective serotonin re-
uptake inhibitor (SSRI), escitalopram. In a phase 1 trial
(NCT01253317) of insulin-like growth factor (IGF-1) in-
volving nine subjects with classic RTT, the RSBQ and
the Anxiety, Depression, and Mood Scale (ADAMS), a
recently developed instrument for assessing these do-
mains in individuals with intellectual disability [30–32],
were administered in a pilot evaluation of IGF-1 efficacy.
This 20-week open-label treatment study showed modest
although consistent improvements in both the RSBQ
Fear/Anxiety and the ADAMS Social Avoidance subscales
[33]. These findings were supported by the partial or
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complete reversal of right-sided alpha band frontal EEG
asymmetry, which has been used as a biomarker of anxiety
or depression [34], in five of the six subjects with available
EEG data [33]. This work suggests that the RSBQ and
ADAMS anxiety- and mood-related subscales have con-
struct validity and could be used as outcome measures in
clinical trials. The IGF-1 phase 1 trial and its preclinical
counterpart using Mecp2 deficient mice [35] also support
the notion that anxiety-like behaviors are a promising
therapeutic target in RTT.
The literature reviewed in the preceding sections em-
phasizes the importance of further elucidating the anx-
iety profile in RTT and underscores the need for
characterizing the psychometric properties of existing
behavioral rating scales such as the RSBQ and the AD-
AMS. Evaluation of behavior in RTT is complicated by
the characteristic marked communication and motor
impairments, including psychomotor slowing, displayed
by most affected individuals. This leads to a greater reli-
ance on parent-based observations since, for ecological
and clinical validity, data need to be collected across dif-
ferent settings and for longer periods of time. The
present study examines the profiles of anxious behavior
in a sample of 74 girls with RTT, with a focus on further
delineating the range of manifestations and their rela-
tionship with other abnormal behaviors and clinically
relevant parameters. We also intended to identify the in-
strument with the best psychometric properties in this
population. For this purpose, we studied the anxiety-
oriented subscales of the RSBQ and the ADAMS and
contrasted them with equivalent subscales of the Aber-
rant Behavior Checklist-Community (ABC-C) [36], the
most widely used instrument for assessing abnormal be-
havior in individuals with intellectual disability [37–39],
and with other measures of abnormal behavior, function-
ing, and quality of life.
Methods
Participants
Data was gathered in 74 girls, ages ranging from 2 to
11 years (M = 5.35; SD = 2.36), with typical RTT and a
confirmed MECP2 mutation. The majority of partici-
pants (n = 57) were pre-screening candidates for the
phase 2 IGF-1 trial (NCT01777542) currently underway
at the Boston Children’s Hospital. Surveys for the
remaining 17 subjects were collected as a part of a sep-
arate study at the BCH aimed at characterizing visual
evoked potentials in young children with RTT and from
the phase 1 IGF-1 trial (pre-treatment). For the three
studies mentioned above, parents are asked to complete
the RSBQ, ADAMS, and a detailed developmental and
medical history questionnaire and to provide copies of
their child’s MECP2 mutation results and growth charts
and pediatric medical records from their first 3 years of
life. If necessary, ambiguities are clarified through a
phone interview with parents and additional records are
requested from the child’s school or early intervention
service provider. Using these records, we determine if
the child meets criteria for typical or atypical RTT and
define the child’s developmental staging in terms of their
regression status. For the purposes of this analysis, any
child that had experienced skill loss within the 6 months
preceding the data of assessment were determined as be-
ing in the active stage of regression (Hagberg stage 2).
All children included in this work were classified as hav-
ing typical Rett syndrome, and nine of the girls between
the ages of 2 and 4 years were determined to be in Hag-
berg stage 2. The vast majority of the individuals (n = 65)
were post-regression (Hagberg stage 3). The aforemen-
tioned studies and their respective data collection proce-
dures were approved by the Institutional Review Board at
the Boston Children’s Hospital.
Measures
Rett Syndrome Behavior Questionnaire (RSBQ)
The RSBQ is an informant/parent-completed measure of
abnormal behaviors typically observed in individuals
with RTT, which is completed by a parent or caregiver
[24]. Each item, grouped into eight domains/subscales
(i.e., General Mood, Breathing Problems, Body Rocking
and Expressionless Face, Hand Behaviors, Repetitive
Face Movements, Night-time Behaviors, Fear/Anxiety,
and Walking/Standing), is scored on a Likert scale of
0–2, according to how well the item describes the in-
dividual’s behavior [24]. For the analyses of anxious
behaviors, we only included the Fear/Anxiety subscale.
Nonetheless, for data interpretation, we also used the
scores of the General Mood and other subscales.
Anxiety Depression and Mood Scale (ADAMS)
\The ADAMS is another parent/caregiver-completed
measure and consists of 28 items, grouped into five sub-
scales (Manic/Hyperactive Behavior, Depressed Mood,
Social Avoidance, General Anxiety, Obsessive Behavior),
and scored on a four-point Likert scale that combines
frequency and severity ratings [31]. It is the only empir-
ically derived instrument for assessing affective disorders
in ID. It is not restricted by the individual’s handicaps,
such as communicative level, and it does not rely on the
DSM framework [30, 31]. The ADAMS was normed in
265 individuals and validated in 129 psychiatric patients
with ID [31], and it has been used to characterize anx-
iety disorders in fragile X syndrome [30]. Previous re-
search examining the correlations between the ADAMS
and ABC-C subscales demonstrated good convergent and
discriminant validities [32]. Our analyses focused on the
Social Avoidance and General Anxiety subscales; however,
other subscales were used for data interpretation.
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Aberrant Behavior Checklist-Community (ABC-C)
The ABC-C is an informant-based behavior rating scale
originally designed for measuring drug and other treat-
ment effects in individuals with ID [36]. Its 58 items
cover a wide range of behaviors, scored between 0–3,
and grouped in five empirically derived subscales (Irrit-
ability, Lethargy/Social Withdrawal, Inappropriate Speech,
Hyperactivity, and Stereotypic Behavior). A revision of the
ABC-C for fragile X syndrome generated another sub-
scale, derived from Lethargy/Social Withdrawal items,
with empirical observation basis termed Social Avoidance
[anxious behaviors] that has also been applied to studies
of autism spectrum disorder [37, 38]. The ABC-C is the
most widely employed measure of abnormal behavior in
ID and autism spectrum disorder, with applications ran-
ging from characterizing behavioral phenotype to measur-
ing response to interventions [37–40]. Our analyses
focused on the two anxiety-related subscales, which
mainly cover social anxiety-related behaviors: Lethargy/
Social Withdrawal and Social Avoidance. As for the RSBQ
and ADAMS, we contrasted scores on these subscales
with the other components of the ABC-C.
Clinical Severity Scale (CSS)
For the past ten years, the CSS has been used to assess
overall clinical severity in the longitudinal Rett Syn-
drome Natural History study (U54 HD061222) involving
over 1100 children and adults with RTT and/or MECP2
mutations [3, 4, 8, 41]. The CSS includes 13 items spe-
cific to the RTT phenotype, both historical and measur-
ing current clinical severity: age of onset of regression,
somatic growth, head growth, independent sitting, am-
bulation (independent or assisted), hand use, scoliosis,
language, non-verbal communication, respiratory dys-
function, autonomic symptoms, onset of stereotypies,
and seizures. Based on the severity or degree of abnor-
mality, each item is scored on a 0–5 scale. In this study,
we only analyzed total CSS scores.
Vineland Adaptive Behavior Scales-II (Vineland-II)
The Vineland-II, survey interview form, was designed to
assess handicapped and non-handicapped persons in
their personal and social functioning [42]. The survey
interview form is administered to a parent or caregiver
using a semi-structured interview format, organized into
four domains: Communication, Daily Living Skills,
Socialization, and Motor Skills. A standard score and
age equivalency are calculated for each domain, as well
as a total score termed Adaptive Behavior Composite. The
VABS-II has been validated in children and adults with ID
and used in populations such as autism spectrum disorder,
fragile X syndrome, Down syndrome, Angelman syn-
drome, and RTT [13, 43–46]. In the present study, we
only analyzed Vineland-II domain standard scores.
Child Health Questionnaire (CHQ)
The Child Health Questionnaire-Parent Form 50 (CHQ-
PF50) is a quality of life scale of 50 items which was de-
signed to measure the physical and psychosocial well-
being of children [47, 48]. The CHQ includes 14 differ-
ent subscales that can be combined to derive overall
Physical and Psychosocial Summary Scores. The CHQ
was normed in children ages 5 to 10 years old and
has been used extensively in children with chronic
diseases and neurodevelopmental disorders, including
RTT [47, 49, 50]. In accordance with previous reports, we
focused on the Physical and Psychosocial Summary Scores
to allow for comparisons.
Statistical analyses
In addition to performing descriptive and data distribu-
tion analyses, we conducted a variety of comparative and
other specialized statistical analyses aiming at delineating
the relationship between the abovementioned measures
and characterizing the psychometric properties of the
anxiety scales. Specific tests are described below in each
“Results” section. The overall analytical strategy can be
summarized as follows: (1) characterizing the RTT co-
hort’s behavioral profile by the three behavioral rating
scales, with emphasis on determining the relative sever-
ity of anxiety-like behaviors with respect to other prob-
lem behaviors; (2) determining the score distribution of
the anxiety-related subscales; (3) examining the relation-
ship between anxiety scale scores and basic parameters
such as age and clinical severity; (4) evaluating the reli-
ability of anxiety scales, specifically internal consistency
by the Cronbach’s alpha, and test-retest and intra-rater
reliabilities; (5) determining convergent and discriminat-
ing validity of the anxiety subscales, measured as the re-
lationship between themselves and with subscales
measuring other constructs; and (6) determining the
functional significance of anxiety scale scores, by evalu-
ating their relationship with the Vineland-II and the
CHQ. Due to data distribution, we used non-parametric
regression analyses and t tests. One- or two-sided/tailed
tests were used, where appropriate, as well as Bonferroni
corrections for multiple comparisons.
Results
General behavior profile in RTT
On the RSBQ, our cohort showed subscale median
scores approaching the measure’s median (based on the
potential score range of each subscale) with exception of
Hand Behaviors, a subscale that reflects the characteris-
tic hand stereotypy of RTT (Table 1). Our cohort’s me-
dian score on the subscale representing anxiety (Fear/
Anxiety) was slightly above the measure’s median. Scores
on the ABC-C subscales were relatively low and, similar
to the RSBQ, only the Stereotypy subscale showed a
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median slightly above the measure’s median. Scores on
the ADAMS were relatively low but comparatively
higher than those on the ABC-C, with only two scales,
Manic/Hyperactive Behavior and General Anxiety, with
medians approaching the measure’s median and values
in the upper range. In general, distribution of scores for
the anxiety-related subscales was comparable to that of
mood subscales and intermediate between those for
stereotypic behavior (upper end) and disruptive behavior
(lower end).
Internal structure of anxiety scales in RTT
We examined the distribution of scores for each of the
subscales using percentile ranks for the scores (Table 1).
The percentile rank of a measure’s score is the percent-
age of scores at the same level or below it [51]. Percent-
ile ranks are useful in demonstrating score distribution
beyond the median, particularly the level of upper range
skewing. In terms of the RSBQ, the Fear/Anxiety sub-
scale showed a comparable percentile rank distribution
to other subscales, whether they measured mood abnor-
malities or other behaviors. The ADAMS Social Avoid-
ance displayed a wide range of scores between the
median and percentile 85 comparable to other ADAMS
subscales but different from the General Anxiety sub-
scale, which had a more even distribution of upper range
scores. The two social anxiety-related ABC-C subscales
showed a similar pattern of score distribution to the AD-
AMS Social Avoidance, which was comparable to other
ABC-C subscales with exception of the Stereotypy
(probably reflecting the relatively high scores on this
subscale in the entire RTT cohort). To our knowledge,
no percentile rank distribution has been reported for the
RSBQ and ABC-C score distribution is quite variable be-
tween and within genetic disorders depending on the
proportion of individuals with severe autistic behavior as
Table 1 Descriptive statistics
CSS Number Min. Max. Skewness SE Kurtosis SE 25th 50th 75th 85th 95th Items α
Total 51 5 32 −0.1 0.3 −0.3 0.7 16.00 20.00 25.00 27.00 30.40 13 –
RSBQ
General Mood 74 0 16 0.5 0.3 −0.6 0.6 4.00 6.00 9.50 13.00 15.30 8 0.88
Body Rocking 74 0 14 0.6 0.3 0.1 0.6 4.00 6.00 8.00 9.00 12.30 7 0.67
Hand Behaviors 74 3 12 −0.5 0.3 −0.5 0.6 6.00 8.00 10.00 10.00 12.00 6 0.63
Fear/Anxiety 74 0 8 −0.1 0.3 −0.7 0.6 3.00 5.00 6.00 7.00 8.00 4 0.73
Breathing Problems 72 0 10 0.3 0.3 −0.9 0.6 2.00 4.50 7.00 8.00 10.00 5 0.76
Repetitive Face Movements 74 0 8 0.0 0.3 −0.8 0.6 2.00 4.00 5.00 6.00 7.00 4 0.53
Night-time Behaviors 72 0 6 0.9 0.3 −0.1 0.6 0.00 1.00 3.00 4.00 5.30 3 0.75
Walking/Standing 73 0 4 −0.1 0.3 −1.3 0.6 1.00 2.00 3.00 4.00 4.00 2 0.62
Total 45 0.88
ADAMS
Manic 74 0 14 0.3 0.3 −0.8 0.6 3.00 6.00 9.00 10.90 13.00 5 0.77
Depressed 74 0 19 1.3 0.3 2.6 0.6 1.00 4.00 6.00 8.00 11.40 7 0.76
Social Avoidance 74 0 16 1.1 0.3 1.3 0.6 2.50 4.00 7.00 8.00 15.30 7 0.80
General Anxiety 74 0 20 1.0 0.3 0.4 0.6 3.00 5.00 9.00 12.20 18.40 7 0.91
Obsessive Behavior 73 0 7 0.7 0.3 −0.4 0.6 1.00 2.00 4.75 6.00 7.35 3 0.60
Total 28 0.92
ABC-C
Irritability 47 0 29 1.3 0.4 1.1 0.7 3.75 7.00 12.00 17.95 27.60 15 0.89
Lethargy/Social Withdrawal 47 0 22 0.7 0.4 −0.4 0.7 4.00 8.00 13.25 16.00 21.30 16 0.78
Stereotypy 47 1 18 −0.2 0.4 0.9 0.7 9.00 11.00 13.25 14.95 17.30 7 0.68
Hyperactivity 47 0 36 1.4 0.4 1.6 0.7 5.00 8.00 14.50 22.00 34.60 16 0.93
Inappropriate Speech 47 0 10 4.4 0.4 23.0 0.7 0.00 0.00 0.00 1.95 3.00 4 0.86
Social Avoidance 47 0 10 1.6 0.4 3.0 0.7 0.00 0.50 3.25 4.00 5.65 4 0.86
Total 58 0.94
There were no differences in the mean/median scores in any of the five anxiety-related scales (in italics), when the nine subjects in the regression stage were
compared with the 65 individuals post-regression. Interpretative guidelines for internal consistency by Cortina [53]: 0.90 or above = excellent; 0.80–0.89 = good;
0.70–0.79 = fair; below 0.70 = unacceptable. In italics are descriptive statistics for the five anxiety-related measures
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we have reported for fragile X syndrome [37, 52] and
Down syndrome [39]. For the ADAMS, the percentile
ranks in our RTT cohort were comparable to those re-
ported by Esbensen and colleagues in 2003 [31] in a
large population of individuals with intellectual disability
and by Rojahn and colleagues in 2011 [32]. Skewness
and kurtosis values were variable among anxiety-related
subscales, with the lowest skewness corresponding to
the RSBQ Fear/Anxiety and lowest kurtosis to the ABC-
C Social Avoidance (Table 1). In general, the values of
these distribution parameters were not substantially dif-
ferent from other construct subscales and comparable or
better than those reported by Rojahn et al. [32].
Anxiety scales, age, and clinical severity in RTT
Relationship with age
We assessed the effect of age on anxiety scale scores in
two ways (Table 2). First, we correlated age as a continu-
ous variable using Spearman regression analyses and
adjusting for multiple comparisons by Bonferroni cor-
rections for the five anxiety-related measures (corrected
p = 0.010) (Table 3). Only the RSBQ Fear/Anxiety dem-
onstrated a near trend level direct relationship. Because
this suggested that older children are more likely to
demonstrate more severe general anxiety, we also
evaluated the effect of age by dividing the cohort into
two groups below (n = 45) and equal or above (n = 29)
6 years. This cutoff was selected because by this age,
most children with RTT have finished their regression and
have entered a more stable stage of the disease, from the
developmental skill viewpoint [4, 7]. However, no age
group differences were found for the RSBQ Fear/Anxiety
or any of the other four anxiety-related subscales (Table 3).
To further probe the question of age, we divided our co-
hort into four age groups (2–4 years, 4–6 years, 6–8 years,
and 8–10+ years) and conducted Welch-Aspin t tests (un-
equal variances) comparing the mean scores of the four
groups on all five anxiety-related subscales and found no
significant differences (data not shown). To address con-
cerns that the nine subjects still in the regression stage of
the disorder could potentially influence our results, we
conducted comparative analyses using non-parametric
t tests between subjects in stage 2 and those in stage
3 and found there were no significant differences
between the two groups in any of the five anxiety-related
subscales. It is important to note that data for all nine sub-
jects still in regression were only available for the RSBQ
and ADAMS. We also compared CSS scores (see next sec-
tion) between these two groups, based on data from four
individuals in stage 2 and 46 subjects in stage 3. While no
significant differences were observed among anxiety sub-
scales, the CSS scores of individuals in the post-regression
stage were significantly higher.
Relationship with clinical severity
We evaluated the relationship between anxiety scales
and clinical severity in two ways. First, by regression
analyses with the CSS, a global measure of severity that
incorporates multiple aspects of the disorder except does
not include behavioral features. Using Spearman regres-
sion and adjusting again for multiple comparisons, with
a corrected alpha of 0.01, we found that the ADAMS
General Anxiety was inversely correlated with the CSS
(p = 0.009). The RSBQ Fear/Anxiety was also inversely
correlated with the CSS at the trend level (p = 0.048),
and the ADAMS Social Avoidance approached an in-
verse trend (p = 0.060). Neither ABC-C subscale was re-
lated to the CSS (Table 3). We complemented this first
approach by comparing scores of those subjects with
mutations considered milder or more severe, in keeping
with previous studies of other phenotypical aspects of
RTT [3, 4, 9]. The “milder” mutation group included
p.Arg133Cys, p.Arg294X, p.Arg306Cys, 3′ truncations,
and other point mutations, while the “more severe” muta-
tion group included p.Arg106Trp, p.Thr158Met,
p.Arg168X, p.Arg255X, p.Arg270X, splice sites, and large
deletions and insertions. Mann-Whitney t tests corrected
for the five comparisons supported the abovementioned
findings, in that girls with “milder” mutations were found
to have higher scores on the ADAMS General Anxiety
(p = 0.013) (Table 4).
For reference, we also evaluated the relationship be-
tween age and both CSS and mutation category, reveal-
ing that subjects in the more severe mutation category
had higher CSS scores (p = 0.009) (Table 4).
Reliability of anxiety scales in RTT
Internal consistency
We measured the internal consistency of all subscales of
the RSBQ, ADAMS, and ABC-C in our RTT cohort
using Cronbach’s alpha, which calculates the level of cor-
relation between a given item on a subscale with the
remaining items on the same subscale (Table 1). Inter-
pretative guidelines for internal consistency [53] state an
alpha coefficient of 0.90 or above is excellent; 0.80–0.89,
good; 0.70–0.79, fair; and below 0.70, unacceptable.
Here, we comment only on the anxiety-related scales.
For the RSBQ, the alpha coefficient for Fear/anxiety







aNine subjects had experienced skill loss within 6 months prior to assessment
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(0.73) was comparable to the one reported by Mount et
al. in their 2002 publication (0.66–0.74) [24]. Alpha coef-
ficients in our RTT cohort for the ADAMS General
Anxiety (0.91) and Social Avoidance (0.80) were compar-
able to findings reported for ID by Esbensen and col-
leagues [31] and by Rojahn et al. [32]. We observed
similar patterns in the ABC-C with alpha coefficients of
0.78 for Lethargy/Social Withdrawal and 0.86 for Social
Avoidance. Thus, alpha coefficients for the anxiety sub-
scales under investigation ranged from fair (0.70–0.79)
to excellent (0.90 and above).
Test-retest reliability
Table 5 depicts our evaluation of test-retest reliability
(n = 34) for the anxiety subscales of the RSBQ and AD-
AMS using intraclass correlation coefficients (ICCs) with
a one-way random effects model (ICC average measures
coefficient) [54, 55]. Guidelines for the interpretation of
inter- and intra-examiner levels of agreement indicate
that when the reliability coefficient (in our case ICC) is
0.75 or greater, the level of clinical significance is excel-
lent, from 0.60 to 0.74, good; 0.40 to 0.59, fair; and
below 0.40, poor. The RSBQ Fear/Anxiety subscale ex-
hibited good retest reliability with an ICC of 0.72, which
is lower than previous findings [24]. The ADAMS Social
Avoidance and General Anxiety subscales both had ex-
cellent retest reliability at 0.80 and 0.81, respectively;
both of which are comparable to previous reports [31].
Intra-rater reliability
We also evaluated intra-rater reliability (Table 5) on the
anxiety subscales of the RSBQ and ADAMS using intraclass
correlation coefficients (ICCs) with a one-way random ef-
fects model (ICC single measure coefficient) [55]. Intra-
rater reliability for the RSBQ Fear/Anxiety was fair (0.57).
To the authors’ knowledge, no reports on the RSBQ’s inter-
or intra-rater reliability have been published. The intra-
rater reliability for the ADAMS Social Avoidance and the
General Anxiety subscales was considered good with a co-
efficient of 0.66 and 0.68, respectively. These findings are
Table 3 Anxiety scale relationship with age and clinical severity
Age CSS
N Spearman’s rho p value aMann-Whitney U aAsymp. sig (two-tailed) Spearman’s rho p value
CSS 51 0.101 0.241 249.500 0.348 – –
RSBQ
Fear/Anxiety 74 0.182 0.060 575.500 0.248 −0.236 0.048
ADAMS
Social Avoidance 74 −0.079 0.251 435.000 0.391 −0.220 0.060
General Anxiety 73 0.120 0.156 563.000 0.446 −0.331* 0.009
ABC-C
Lethargy/Social Withdrawal 47 0.010 0.474 218.500 0.623 −0.138 0.177
Social Avoidance 47 0.006 0.484 223.000 0.676 −0.150 0.157
In bold, significant and trend level p values
*Adjusted for multiple [5] comparisons (excluding CSS) with Bonferroni corrections for the five anxiety-related measures, adjusted p = 0.01
aAge grouping <6 years (n = 45), >6 years (n = 29)
Table 4 Anxiety scale relationship with MECP2 mutation severity
Mild (n = 26) Severe (n = 46) Mutation differences
N Median SD Median SD aMann-Whitney U aAsymp. sig (two-tailed)
CSS 51 18.00 5.47 22.00 5.54 175.00* 0.009
RSBQ
Fear/anxiety 72 5.00 2.11 4.00 2.01 504.50 0.267
ADAMS
Social avoidance 72 4.00 3.29 4.00 3.69 515.50 0.330
General anxiety 71 7.00 4.32 5.00 4.80 377.00 0.013
ABC-C
Lethargy/social withdrawal 47 9.50 6.46 6.50 4.47 208.00 0.207
Social avoidance 47 1.50 2.79 0.00 1.34 208.50 0.179
In bold, significant and trend-level p values
*Adjusted for multiple [5] comparisons (excluding CSS) with Bonferroni corrections for the five anxiety-related measures, adjusted p = 0.01
aGrouping mild vs. severe MECP2 mutation
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higher than those reported by Esbensen et al. [31] for intel-
lectual disability, particularly so for the General Anxiety
subscale. Due to differences in study design, we were un-
able to calculate ICCs for subscales of the ABC-C.
Convergent and discriminant validity of anxiety scales
in RTT
We estimated convergent validity by measuring the level
of agreement between the five anxiety-related subscales.
Discriminant validity was determined by the level of dis-
agreement between these five subscales and subscales of
the RSBQ and ABC-C measuring a different construct
(e.g., RSBQ Breathing Problems, ABC-C Stereotypy). Be-
cause of the close relationship between anxiety and
mood, we hypothesized that there would be an inter-
mediate level of agreement between subscales measuring
these two constructs. Therefore, mood-related subscales
would not be informative in terms of either convergent
or discriminant validity. These correlations were per-
formed by one-tailed Spearman regression analyses since
we expect all relationships to be in the same direction.
As shown in Table 6, which includes the five anxiety-
related subscales as well as one of the mood subscales
(RSBQ General Mood) and another subscale partially
reflecting mood behaviors (ABC-C Irritability), there
were strong correlations between the three social anxiety
subscales (ADAMS Social Avoidance, ABC-C Lethargy/
Social Withdrawal, ABC-C Social Avoidance) and be-
tween the two general anxiety subscales (RSBQ Fear/
Anxiety, ADAMS General Anxiety). While the ADAMS
Social Avoidance was also correlated with the ADAMS
General Anxiety and the RSBQ Fear/Anxiety, these rela-
tionships were weaker. On the other hand, the ABC-C
social subscales were borderline or not correlated with
the two general anxiety subscales. Table 6 also demon-
strates that anxiety measures correlated more variably
with mood subscales. In terms of discriminant validity,
the two general anxiety subscales were also correlated
with subscales measuring other constructs (only correla-
tions with ABC-C Irritability shown on Table 6; other
examples include RSBQ Body Rocking and ABC-C
Hyperactivity). In contrast, with exception of subscales
representing stereotypic behavior, the social anxiety scales
correlated only with the mood or anxiety measures.
Functional correlates of anxiety scales in RTT
Anxiety and adaptive behavior
Using two-tailed Spearman regression analyses, we
assessed how anxiety may influence adaptive behavior by
correlating the five anxiety-related subscales with the
Vineland-II (Table 7). Since the Vineland-II has four sub-
domains/scales, we implemented Bonferroni corrections
to adjust for multiple comparisons (adjusted p = 0.0125).
We only observed weak inverse relationships between
the ADAMS Social Avoidance and the Vineland-II
Communication (p = 0.12), the adaptive behavior do-
main more closely related to overall cognitive func-
tion, and the ABC Lethargy/Social Withdrawal and
the Vineland-II Daily Living (p = 0.10). A stronger
Table 5 Test-retest reliability and intra-rater reliability for anxiety subscales
Number Retest 95 % CI Intra-rater 95 % CI
RSBQ
General Mood 34 0.86 0.72–0.93 0.75 0.56–0.87
Body Rocking and Expressionless Face 34 0.90 0.80–0.95 0.82 0.67–0.90
Hand Behaviors 34 0.83 0.67–0.92 0.71 0.49–84
Fear/Anxiety 34 0.72 0.45–0.86 0.57 0.29–0.76
Breathing Problems 34 0.91 0.82–0.95 0.83 0.69–0.91
Repetitive Face Movements 34 0.78 0.56–0.88 0.64 0.38–0.79
Night-time Behaviors 34 0.94 0.88–97 0.89 0.79–0.94
Walking/Standing 34 0.74 0.49–0.87 0.59 0.32–0.77
Mean 0.84 – 0.73 –
ADAMS
Manic/Hyperactive Behavior 34 0.77 0.54–0.88 0.62 0.37–0.79
Depressed Mood 33 0.72 0.44–0.86 0.57 0.29–0.76
Social Avoidance 34 0.80 0.59–0.89 0.66 0.42–81
General Anxiety 33 0.81 0.61–0.91 0.68 0.45–0.83
Obsessive/Compulsive Behavior 33 0.80 0.59–0.89 0.66 0.42–0.82
Mean 0.78 – 0.64 –
In italics are ICCs for anxiety-related subscales and 95 % confidence interval (CI)
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direct correlation was found between the ADAMS General
Anxiety and the Vineland-II Motor (p = 0.04). Similar rela-
tionships with motor function were found for the RSBQ
General Mood and the ABC-C Irritability. These findings
suggest that RTT children with more severe social avoid-
ance have slightly worse adaptive behavior skills and that
those with more severe general anxiety or mood abnor-
malities have better motor skills.
Anxiety and quality of life
Using the same analytical strategy we employed for
adaptive behavior, we also evaluated the impact of















RSBQ General Mood 1.000 0.430b 0.362b 0.347b 0.665b 0.434b 0.356b
N 74 74 74 73 47 47 47
RSBQ Fear/Anxiety 0.296b 0.626b 0.331a 0.160 0.218
N 74 73 47 47 47
ADAMS Social
Avoidance
0.411b 0.277a 0.588b 0.613b




N 46 46 46






ABC Social Avoidance 1.000
N 47
aCorrelation is significant at the 0.05 level (one-tailed)
bCorrelation is significant at the 0.01 level (one-tailed)

















−0.075 0.030 −0.242 0.087 −0.017 −0.133 −0.151
Sig. 0.637 0.853 0.122 0.585 0.916 0.401 0.340





0.011 0.086 −0.158 −0.020 −0.124 −0.255 −0.223
Sig. 0.944 0.589 0.319 0.897 0.436 0.104 0.156
N 42 42 42 42 42 42 42
Socialization Corr.
coeff.
−0.205 −0.182 −0.107 −0.141 −0.186 −0.189 −0.207
Sig. 0.193 0.248 0.499 0.374 0.239 0.231 0.189
N 42 42 42 42 42 42 42
Motor Skills Corr.
coeff.
0.344* 0.218 0.074 0.312* 0.385** 0.087 0.140
Sig. 0.026 0.166 0.642 0.044 0.012 0.582 0.376
N 42 42 42 42 42 42 42
Two-tailed Spearman’s rho, adjusted for multiple comparisons with Bonferroni corrections for the four Vineland-II domains (p = 0.05/4, adjusted alpha 0.0125).
*p = 0.0125–0.05 (trend); **p < 0.0125 (significant)
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anxiety on quality of life in our RTT cohort (Table 8).
We analyzed the two general scores of the CHQ, a qual-
ity of life measured validated for RTT [50]: the CHQ
Physical Summary Score and the CHQ Psychosocial
Summary Score. Considering an adjusted significance
alpha of 0.025, only the ADAMS Social Avoidance was
inversely correlated with the CHQ Psychosocial Scale at
a trend level (p = 0.041). Including again other non-
anxiety subscales in the analyses, we also found that the
ABC-C Irritability subscale was strongly inversely corre-
lated with the CHQ Psychosocial Scale (p = 0.002). These
findings demonstrate that more severe selective anxiety
and mood/disruptive behavior symptoms lead to a worse
quality of life, which is in line with similar results using
the ABC-C in fragile X syndrome [56].
Discussion
Behavioral abnormalities are an important component of
the phenotype of RTT [13, 16, 24, 33]. Nonetheless, they
are not included in the diagnostic criteria of the disorder
and their characterization is still limited. Until recently,
most studies had focused on the autistic features of
RTT. The incorporation of the RSBQ to the battery of
instruments for evaluating individuals with RTT in 2002
brought attention to the frequency and severity of
anxiety-like and other problem behaviors in RTT. Never-
theless, no systematic evaluation of anxious behaviors in
RTT has been conducted. Taking into consideration the
marked communication and motor impairments in the
disorder, it is critical to delineate behaviors evaluated by
standardized instruments in suitable RTT cohorts and
not to assume that these measures are adequate for the
disorder. Here, we report on a comprehensive assess-
ment of the anxiety-related subscales of the RSBQ, AD-
AMS, and ABC-C. We determined both the profiles of
anxious behaviors in RTT and the psychometric proper-
ties of the abovementioned instruments. We found that
anxiety-like behaviors were comparable in severity to
other behavioral domains such as mood abnormalities
and disruptive behavior, but less pervasive than stereo-
typic behaviors. We also determined that, although rela-
tively constant during childhood, anxious behaviors were
more prominent in RTT children with milder neurologic
impairment. Finally, while reliability measures were sat-
isfactory for all five anxiety-related subscales, those
evaluating the social domain showed better concurrent
(convergent and discriminant) validity and greater func-
tional implications. Based on the available data, the AD-
AMS Social Avoidance subscale displayed the best
overall psychometric profile.
The RSBQ, ADAMS, and ABC-C profiles of our RTT
cohort demonstrate a wide range of scores, with a rela-
tive prominence of stereotypic and repetitive behaviors
that are captured mainly by the RSBQ Hand Behaviors
and ABC-C Stereotypy subscales. Therefore, these scores
are driven by the persistent hand stereotypies which are
a cardinal feature of the disorder [7, 13]. Although some
children with RTT display maximum scores on the
anxiety-related subscales, the median scores for these
measures were relatively low and predominantly below
the range midpoint. Distribution of scores for the
anxiety-related subscales was comparable to that of the
mood subscales and intermediate between those for the
stereotypic behavior and disruptive behavior subscales.
Percentile ranks and skewness and kurtosis measures
complemented the analyses of score distributions, re-
vealing that, in general terms, anxiety-related subscales
were not substantially different from subscales measur-
ing other behavioral domains. We could conclude that
anxious behaviors are relatively moderate in severity in
RTT, and that general anxiety tends to be slightly more
severe than social anxiety in this population. To deter-
mine how representative our cohort was, we compared
its RSBQ profile with those published by Mount and col-
leagues (n = 139) and more recently by Cianfaglione
et al. (n = 91). With the exception of the General Mood
in the 2002 study, raw scores reported here are compar-
able to the two previous studies. Since no data have been




















−0.165 0.055 −0.031 0.068 −0.145 −0.015 0.213
Sig. 0.328 0.744 0.856 0.688 0.422 0.936 0.234





−0.310 −0.193 −0.338* −0.298 −0.509** −0.090 −0.060
Sig. 0.062 0.252 0.041 0.073 0.002 0.620 0.739
N 37 37 37 37 33 33 33
Two-tailed Spearman’s rho, adjusted for multiple comparisons with Bonferroni corrections for the two CHQ summary scores (p = 0.05/2, adjusted alpha: 0.025)
*p = 0.025–0.05 (trend); **p < 0.025 (significant)
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published on ADAMS and ABC-C profiles in children
with RTT (i.e., only one ABC-C study in adults with
RTT has been published [57]), it is difficult to evaluate
the representativeness of our cohort for these scales.
Nevertheless, the ADAMS percentile ranks in this study
were comparable to those of a large cohort with ID [31].
We found that age did not influence scores on anxiety-
related subscales, which makes these measures suitable
for a large segment of the RTT population. Since most
of our cohort was younger than 8 years, and we included
9 subjects still in regression whose scores were compar-
able to the 65 in post-regression, we are confident that
the three measures can be used in young children. We
found that clinical severity only influenced the general
anxiety measures, with neurologically less affected indi-
viduals having higher scores on the RSBQ Fear/Anxiety
and ADAMS General Anxiety. This pattern was also
found for other subscales, notably the ABC-C Irritability
which represents disruptive behavior (data not shown).
The fact that less impaired children with RTT present
with more severe behavioral problems is not surprising
since this has been the clinical impression for years.
Whether these relationships are related to the child’s
higher cognition and awareness of the environment, or
because they are easier to assess due to better communi-
cation and motor skills, remains unclear.
The possibility that anxiety-related measures can be
applied to a wide range of individuals with RTT does
not necessarily mean that they are suitable from the
psychometric viewpoint. The development of the
RSBQ included a psychometric validation [24]; a re-
cent re-evaluation expanded these analyses and dem-
onstrated a high correlation between five of the
RSBQ subscales that included the Fear/Anxiety sub-
scale [16]. The latter actually correlated strongly with
all other subscales with the exception of Walking/
Standing, which suggests relative lack of specificity.
Some efforts have also been made at delineating the
psychometric properties of the ABC-C and ADAMS
in groups of individuals with ID [30–32]; whether the
latter data can be applied to RTT is unclear. For
these reasons, we assessed the reliability and validity
of the five anxiety-related subscales of the RSBQ, AD-
AMS, and ABC-C. Reliability was examined in three
different ways: internal consistency, test-retest reliabil-
ity, and intra-rater reliability. Cronbach’s alpha ana-
lyses showed that three of the subscales were in the
good to excellent range, while the RSBQ Fear/Anxiety
and the ABC Lethargy/Social Withdrawal were con-
sidered only fair. This finding contrasted with a less
favorable assessment of the RSBQ Fear/Anxiety by
Mount and colleagues (2002). Test-retest reliability
was only performed on the RSBQ and ADAMS and
demonstrated the three anxiety-related subscales were
adequate, although the two ADAMS measures had
better intraclass correlation coefficients. Intra-rater re-
liability analyses conducted on the same subscales
showed a similar profile to test-retest reliability, with
the ADAMS scales faring better than the RSBQ Fear/
Anxiety, but all three were considered adequate.
Altogether, these data indicate that the ADAMS anx-
iety subscales meet most criteria for adequate reliabil-
ity. Unfortunately, we could not draw definitive
conclusions about the ABC-C subscales since we were
unable to evaluate its test-retest or intra-rater
reliability.
Because of the lack of appropriate gold standards,
validity of behavioral instruments is in general
assessed by examining construct or concurrent valid-
ity. This means establishing that the measure is sig-
nificant (and usually directly) correlated with other
measures that evaluate the same construct (conver-
gent validity), in this case anxiety. Complementing
this, discriminant validity is demonstrated by poor
correlations with measures of unrelated constructs
[32]. These two types of validity can be thought of as
sensitivity and specificity, respectively, and should be
considered with caution as it is difficult to fully deter-
mine the relationship between behavioral constructs.
Our data demonstrate that the three social anxiety
subscales were strongly correlated among themselves
and, among them, only the ADAMS Social Avoidance
correlated with the two measures of general anxiety.
On the other hand, the ADAMS General Anxiety and
the RSBQ Fear/Anxiety were strongly correlated with
each other. Although convergent validity was similar
for general and social anxiety measures, the main dif-
ference was in terms of discriminant validity. While
the general anxiety subscales correlated with measures
of mood and other constructs such as hyperactivity,
the social subscale correlations were restricted to
mood and stereotypic behavior (excluding motor ste-
reotypies). We can conclude that, in terms of concur-
rent validity, the ADAMS Social Avoidance, ABC-C
Lethargy/Social Withdrawal, and ABC-C Social Avoid-
ance are the best measures. Beyond psychometric
properties, the value of behavioral instruments is also
determined by their ability to measure clinically or
functionally meaningful behaviors. This is a particu-
larly important feature when selecting a behavioral in-
strument as an outcome measure in intervention
studies. We used two complementary instruments to
determine the functional implications of anxiety-
related measures in RTT: adaptive behavior, a con-
struct that evaluates cognition in practical aspects,
and quality of life [46, 58]. Relationships between
anxiety scales and adaptive behavior measures were
weak; however, higher scores (i.e., more severe) on the
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ADAMS Social Avoidance were inversely correlated to a
measure of psychosocial quality of life, indicating reduced
psychosocial well-being.
It has been difficult to measure anxiety and mood ab-
normalities in individuals with ID. The best-established
measure in the field, the ABC-C, emphasizes social type
of anxiety although it also includes social indifferent be-
haviors more characterized in autism spectrum disorder
[37, 38]. The ABC-C Social Avoidance, which has been
derived from the ABC-C Lethargy/Social Withdrawal,
represents an attempt at isolating more social anxiety-
specific items of the ABC-C [38]. Consequently, the
introduction of the ADAMS was an attempt at better
delineating both social and non-social forms of anxiety
in these populations [30, 31]. Our data suggest that, al-
though all anxiety measures are adequate in RTT, social
anxiety subscales and in particular the ADAMS Social
Avoidance has the most solid psychometric foundation.
Shortcomings of these anxiety measures seem to relate
to their scoring structure, particularly the small number
of items and the compressed range of scores. For in-
stance, the RSBQ is scored on a three-point Likert scale
(0–2) while the ADAMS and the ABC-C use a four-
point Likert scale (0–3). The number of items included
in a subscale is also important; the RSBQ Fear/Anxiety
has only four items vs. the ADAMS General Anxiety
subscale which has seven. However, content is also im-
portant; like the RSBQ Fear/Anxiety, the ABC-C Social
Avoidance has only four items but exhibits a more favor-
able psychometric profile.
Conclusions
This study represents the first attempt at systematically
examining anxiety-like behavior in RTT using standard-
ized instruments, concluding that social avoidance/anx-
iety is the most adequately measured anxious behavior.
Anxiety-like behavior seems to be an important compo-
nent of the RTT phenotype, with quality of life implica-
tions [12, 16]. Our reliance on informant-based behavior
rating scales in RTT is an issue that cannot be underesti-
mated. In addition to the aforementioned communica-
tion and motor deficits, abnormal muscle tone, and
hand function impairments, psychomotor slowing (due
to dyspraxia, etc.) is highly prevalent in RTT. This leads
to difficulties in obtaining representative samples of be-
havior, unless observations are made for long periods of
time in more naturalistic settings. This makes parents
and caregivers critical informants in RTT and has led to
other evaluation strategies such as home video assess-
ments [59]. Our study had several limitations mentioned
in the preceding sections. In addition to the inclusion of
a number of subjects still undergoing regression and all
subjects being under age 11, there was no comparison
group with ID to determine the specificity of the anxious
behavior profiles in RTT. We were also unable to
complete reliability assessments of the ABC-C, and a
number of our analyses had variable sample sizes. How-
ever, comparisons between subgroups with complete
data with those with partial data did not show significant
differences in anxiety-related measures. Additionally, the
subjects’ regression status did not appear to influence
their scores on anxiety scales. Nonetheless, the subject
sample may have been biased since a large proportion of
the participants were applicants to an ongoing phase 2
trial of IGF-1 in our institution. Although parents are
not told the specific subscales and cutoff scores used to
determine inclusion, parents are told that participants
must demonstrate a “specific behavior profile based on
standardized questionnaires.” Despite these and other
possible shortcomings, the data reported here could
serve as basis for the study of anxiety in RTT and for de-
veloping new assessment tools. The fact that anxiety-
related scores were among the most responsive to IGF-1
in a recent trial [33] emphasizes the importance of de-
fining an adequate method for measuring this behavioral
abnormality. These findings elucidate the prevalence and
severity of anxiety symptoms in RTT and lay the founda-
tion for use of the aforementioned measures in future
clinical trials.
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